Still scanning every room for danger. Still waking at 3am with your heart racing. Still cancelling plans because somewhere the public feels too unpredictable. If trauma-focused therapy and medication have not given you enough relief, it is reasonable to ask whether another regulated option exists. PTSD medical cannabis treatment in the UK is not automatic or guaranteed, but a specialist assessment can explore whether it may be clinically appropriate for your individual situation.
Can PTSD medical cannabis treatment be considered after standard care in the UK?
Medical cannabis may be considered in the UK for adults with PTSD when standard treatments have not provided enough relief and a specialist finds it clinically appropriate. It is not automatically prescribed for the diagnosis itself. Evidence for PTSD-specific outcomes is primarily observational, so treatment needs an individual assessment and ongoing follow-up. ¹
Private specialist clinics commonly look for a confirmed PTSD diagnosis, a documented record of treatments and therapies tried, and no clear contraindications. PTSD alone does not qualify someone automatically. The specialist decides whether the potential benefits outweigh the risks for that person, given their full clinical picture.
What “treatment not working” can mean
Treatment not working does not always mean a medicine had no effect at all. It can mean symptoms remain disruptive enough to affect daily life, work, sleep or relationships despite following the plan. It can mean side effects that make continuing difficult. It can mean the benefit was partial but not enough. A clinician needs your honest account of what you tried, for how long, and what happened. This is not a barrier to be overcome but information that helps them assess safely. Do not stop therapy or prescribed medicines before or during an assessment without advice from the clinician managing your care. ²
Medical records needed for a cannabis consultation explains what documentation helps.
PTSD medical cannabis UK evidence: what research can and cannot say
UK Medical Cannabis Registry data for PTSD reported associations with improvements in sleep, anxiety and quality of life over the follow-up period. ³ These are associations, not proof of cause and effect. The Medical Cannabis Clinicians Society notes that observational signals for PTSD are among the more consistent across conditions, but the evidence base does not yet meet the threshold for standard treatment guidelines. ⁴ NICE recommends trauma-focused CBT and EMDR as first-line treatments. PTSD medical cannabis treatment should not replace therapy, and if you have not yet had access to trauma-focused therapy, pursuing that should come first.
What a specialist will assess before considering PTSD medical cannabis treatment
A clinician will want to review your diagnosis, treatments and therapies tried, current medicines and interactions, substance use history, and any personal or family history of psychosis or bipolar disorder. Driving responsibilities and pregnancy where applicable are also relevant. Within PTSD medical cannabis practice, assessments in the UK are particularly careful around psychiatric history, as THC can worsen anxiety, paranoia or psychotic symptoms in some people.
Consider an adult with diagnosed PTSD who completed trauma-focused CBT with partial benefit, and tried an SSRI that caused side effects they could not tolerate long enough to complete a full trial. Nightmares, hypervigilance and avoidance continue to affect work and relationships. This is the kind of history a clinician would review. It does not indicate what the outcome would be.
How private medical-cannabis care works at LeafEase
LeafEase is a Care Quality Commission (CQC)-registered private medical cannabis clinic. Consultations take place by video with a GMC-registered specialist clinician who reviews your full history before any prescribing decision is made. If a CBPM prescription is considered appropriate, it is delivered to your home in plain, discreet packaging with no indication of the contents on the outside.
Ongoing care through LeafEase Advantage means you have continuity with the same clinician, scheduled follow-up consultations, reviews built around your daily routine and responsibilities, and free home delivery. Medical cannabis has been prescribed only five times on the NHS since it became legal in 2018.⁵ For most patients, the private route is the only realistic path to a specialist CBPM assessment.
When it may not be the right next step
A specialist may decide that a CBPM is not suitable because of safety concerns, complex psychiatric history, interactions with current medicines, or because other care steps would be more appropriate first. This is the clinical process working correctly, not a failure.
If you feel at immediate risk, are having thoughts of harming yourself or cannot keep yourself safe, please use emergency services (999), NHS 111 or an urgent mental health service rather than waiting for a clinic appointment. These are not situations for a private clinic consultation.
If your PTSD treatment has not given you enough relief and you want a specialist to review your history, you can check your eligibility for a PTSD medical cannabis UK assessment. The check takes a few minutes and does not commit you to a consultation.
Frequently Asked Questions
Can you get medical cannabis for PTSD in the UK?
Yes, through a private specialist clinic where a GMC-registered clinician finds it clinically appropriate after an individual assessment. It is not available through most GPs and requires a specialist prescription. Having a PTSD diagnosis does not automatically qualify you for a prescription.
What treatments do I need to have tried before a PTSD cannabis assessment?
Most private clinics look for evidence that at least two appropriate treatments or therapies have been tried without sufficient benefit. For PTSD, this typically includes trauma-focused therapy such as CBT or EMDR, and often a prescribed medicine. A clinician will review the full history rather than applying a rigid rule.
Is medical cannabis available on the NHS for PTSD?
No, not as a standard treatment. NHS prescribing of cannabis-based medicines remains confined to a very small number of conditions. For PTSD, access is through private specialist clinics only.
Can medical cannabis replace PTSD therapy or antidepressants?
No. A responsible clinician would not prescribe cannabis as a replacement for trauma-focused therapy. NICE recommends trauma-focused CBT and EMDR as first-line treatments. If you have not had adequate access to therapy, raising this with your GP or care team is important alongside exploring any other options.
Will a history of anxiety or depression affect eligibility?
Not automatically. Anxiety and depression are common alongside PTSD and are noted in the assessment. A history of psychosis or bipolar disorder requires more careful review because of known risks associated with THC-containing products. A specialist assesses the full picture individually.
Can I drive with a medical cannabis prescription for PTSD?
You must not drive if you feel drowsy, dizzy, impaired or otherwise affected, regardless of whether your prescription is legal. Your clinician will discuss driving responsibilities with you during the assessment and should be your first point of contact if you have concerns about impairment.
References
1] NHS (2022) Post-traumatic stress disorder (PTSD). Available at: https://www.nhs.uk/mental-health/conditions/post-traumatic-stress-disorder-ptsd/overview/ Accessed: September 2026].
2] National Institute for Health and Care Excellence (2018) Post-traumatic stress disorder. NICE Guideline NG116. Available at: https://www.nice.org.uk/guidance/ng116 Accessed: September 2026].
3] Pillai, M. et al. (2022) UK Medical Cannabis Registry: an analysis of clinical outcomes of cannabis-based medicinal products for post-traumatic stress disorder. Expert Review of Neurotherapeutics. Available at: https://www.tandfonline.com/doi/full/10.1080/14737175.2025.2490539 Accessed: September 2026].
4] Medical Cannabis Clinicians Society (2024) Medical cannabis and mental health: evidence, clinical judgment and responsible prescribing. Available at: https://www.ukmccs.org/guidance-publications/medical-cannabis-and-mental-health-evidence-clinical-judgment-and-responsible-prescribing Accessed: September 2026].
5] The Pharmaceutical Journal (2023) Demystifying medical cannabis: five years on from legalisation. Available at: https://pharmaceutical-journal.com/article/feature/demystifying-medical-cannabis-five-years-on-from-legalisation Accessed: September 2026].
